Renal Failure Warnings for Reclast®
The FDA has initiated an additional warning for Reclast® on September 1, 2011 for renal failure and kidney impairment; and warns that patients with kidney dysfunction should not use this drug. Reclast's (zoledronic acid) label was originally changed in 2009, recommending creatinine clearance testing prior to administration, with a... Read more


